Friday 6 November 2026 Export LNTH’s income statement to Excel — free account

Lantheus Holdings, Inc.

LNTH Healthcare Drug Manufacturers Specialty & Generic

Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.

Revenue: +1.54%
EPS: −17.1%
Free cash flow: +7.71%
Total debt: +0.52%

Quarter to September 2026, against a year earlier

Revenue growth 5 yrs

100.54 0.16 −0.16%

Follow LNTH

Alert me

Market cap: $6.6B
P/E: 24.3×
Fwd P/E: 21.3×
Dividend yield: —
F-score: 5/9
Altman Z: 4.25
Beneish M: −2.23
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Lantheus Holdings, Inc. 10-Q filed Aug 6, 2026

Fiscal Q2 2026 · Period ended Jun 30, 2026 · Filed Aug 6, 2026 · accepted 8:01 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis Part II, Item 1A, Risk Factors

Part II, Item 1A, Risk Factors, against the 10-Q filed May 7, 2026: 29 added · 9 modified